1[1]Harvey G. Kemp JR. Left ventricular function in patients with the anginal syndrome and normal coronary arteriograms . Am J Cardiol, 1973,32: 375-376. 被引量：1
2[2]Kaski JC, Rosano GM, Collins P, et al. Clinical characteristics and left ventricular function. Long- term follow - up study. J Am Coll Cardiol,1995, 26: 1562- 1563. 被引量：1
3[3]Atienza F, Velasco JA, Brown S, et al. Assessment of quality of life in patients with chest pain and normal coronary arteriogram (CSX) using a specific questionnaire. Clin Cardiol, 1999, 22: 283-290. 被引量：1
4[4]Kostin VI, Karpov RS. The quality of life in patients with cardiac CSX Article in Russian. Klin Med (Mosk) , 2001, 79: 25-27. 被引量：1
5[5]Reis SE, Holubkov R, Conrad Smith A J, et al. Coronary microvascular dysfunction is highly prevalent in women with chest pain in the absence of coronary artery disease: results from the NHLBI WISE study. Am Heart J, 2001, 141:735 - 741. 被引量：1
6[6]Rosano GM, Collins P, Kaski JC, et al. CSX in women is associated with oestrogen deficiency. Eur Heart J, 1995, 16: 610-614. 被引量：1
7[7]Lanza GA, Andreotti F, Sestito A, et al. Platelet aggregability in cardiac CSX. Eur Heart J , 2001, 22: 1924- 1930. 被引量：1
8[8]Chen LC, Chen JW, Wu MH. Differential coronary calcification on electron- beam CT between CSX and coronary artery disease in patients with chronic stable angina pectoris. Chest, 2001, 120:1525 - 1533. 被引量：1
9[9]Shemesh J, Fisman EZ, Tenenbaum A, et al. Coronary artery calcification in women with CSX: usefulness of double - helical CT for detection.Radiology, 1997, 205: 697- 700. 被引量：1
10[10]WienekeH, ZanderC, Herz. Non- invasive characterization of cardiac microvascular disease by nuclear medicine using single - photon emission. Tomography, 1999, 24: 515-521. 被引量：1
2Lam PM,Chung TK,Haines C.Where are we with postmenopausal hormone therapy in 2005[J].Gyencol Endocrinol,2005,21(5):248. 被引量：1
3Bryant HU,Dere WH.Selective estrogen receptor modulators:an alternative to hormone replacement therapy[J].Proc Soc Exp Bio Med,1998,217(1):45. 被引量：1
4Waters DD.Estrogen therapy for unstable angina:another bump for the bandwagon[J].J Am Coll Cardiol,2002,39(2):238. 被引量：1
5Barrett-Connor E,Grady D,Sashegi A,et al.Raloxifene and cardiovascular events in osteoporotic postmenopausal women.Four-year results from the MORE(Multiple Outcomes of Raloxifene Evaluation) randomized trial[J].JAMA,2002,287(7):847. 被引量：1
6Duvernoy CS,Kulkarni PM,Dowsett SA,et al.Vascular events in the multiple outcomes of raloxifene evaluation(MORE) trial:incidence,patient characteristics,and effect of raloxifene[J].Menopause,2005,12(4):444. 被引量：1
7Francucci CM,Camilletti A,Boscaro M.Raloxifene and cardiovascular health:its relationship to lipid and glucose metabolism,hemostatic and inflammation factors and cardiovascular function in postmenopausal women[J].Curr Pharm Des,2005,11(32):4 187. 被引量：1
8Walsh BW,Kuller LH,Wild RA,et al.Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women[J].JAMA,1998,279 (18):1445. 被引量：1
9Francucci CM,Pantaleo D,Iori N,et al.Effects of raloxifene on body fat distribution and lipid profile in healthy post-menopausal women[J].J Endocrinol Invest,2005,28(7):623. 被引量：1
10Bjarnason NH,Haarbo J,Byrjalsen I,et al.Raloxifene inhibits aortic accumulation of cholesterol in ovariectomized,cholesterol-fed rabbits[J].Circulation,1997,96(6):1 964. 被引量：1
